Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The amounts reported in boxes 6, 8, and 9 represent 1,085,934 shares of common stock, par value $0.001 per share ("Common Stock"), of NeuroOne Medical Technologies Corporation (the "Company"), held in a joint account with Brian Pratt's spouse. The percentage in box 11 is based on 8,702,982 shares of Common Stock outstanding as of June 10, 2026, as reported in Amendment No. 1 to the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on June 12, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The amounts reported in boxes 6, 8, and 9 represent 1,085,934 shares of common stock, par value $0.001 per share ("Common Stock"), of NeuroOne Medical Technologies Corporation (the "Company"), held in a joint account with Barbara Pratt's spouse. The percentage in box 11 is based on 8,702,982 shares of Common Stock outstanding as of June 10, 2026, as reported in Amendment No. 1 to the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on June 12, 2026.


SCHEDULE 13G



 
Brian Pratt
 
Signature:/s/ Brian Pratt
Name/Title:Brian Pratt
Date:07/14/2026
 
Barbara Pratt
 
Signature:/s/ Barbara Pratt
Name/Title:Barbara Pratt
Date:07/14/2026
Exhibit Information

Joint Filing Agreement, dated as of April 21, 2026, by and between the Reporting Persons, attached hereto.


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EXHIBIT 1